- /
- Supported exchanges
- / US
- / BWAY.NASDAQ
Brainsway Ltd (BWAY NASDAQ) stock market data APIs
Brainsway Ltd Financial Data Overview
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Brainsway Ltd (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Brainsway Ltd data using free add-ons & libraries
Get Brainsway Ltd Fundamental Data
Brainsway Ltd Fundamental data includes:
- Net Revenue: 56 220 K
- EBITDA: 6 616 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-31
- EPS/Forecast: 0.05
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Brainsway Ltd News
New
Brainsway Q1 Earnings Call Highlights
Brainsway logo Key Points Interested in Brainsway Ltd. Sponsored ADR? Here are five stocks we like better. BrainsWay posted strong Q1 results with revenue up 35% year over year to $15.5 million, its...
Full Transcript: BrainsWay Q1 2026 Earnings Call
BrainsWay (NASDAQ:BWAY) released first-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For ...
BrainsWay shares slip despite first-quarter earnings beat and strong growth (BWAY)
medical research microscope ©NIH Lab Research Shares of BrainsWay (NASDAQ:BWAY) fell more than 2% in premarket trading on Wednesday after investors reacted to the company’s maintained full-year gu...
BrainsWay GAAP EPS of $0.06 beats by $0.01, revenue of $15.53M beats by $0.91M
* BrainsWay press release [https://seekingalpha.com/pr/20512989-brainsway-reports-first-quarter-2026-financial-results-and-operational-highlights] (BWAY [https://seekingalpha.com/symbol/BWAY]): Q1 G...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.